[{"AccountsPayableCurrent_0_Q2_USD":34222000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":100863000.0,"ProfitLoss_2_Q2_USD":27905000.0,"ProfitLoss_1_Q2_USD":10828000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":197941000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":22371000.0,"PreferredStockValue_0_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":100000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":1.0,"PaymentsToAcquireProductiveAssets_2_Q2_USD":5235000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":230586000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":26864000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":14000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":235000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":17956000.0,"OtherIndefiniteLivedIntangibleAssets_0_Q2_USD":15359000.0,"NumberOfReportableSegments_2_Q2_Segment":2.0,"OperatingExpenses_1_Q2_USD":48125000.0,"OperatingExpenses_2_Q2_USD":86388000.0,"OperatingIncomeLoss_1_Q2_USD":12469000.0,"OperatingIncomeLoss_2_Q2_USD":34214000.0,"OperatingLeaseLiability_0_Q2_USD":2181000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":4332000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2171000.0,"OtherAssetsNoncurrent_0_Q2_USD":2018000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-7649000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-12272000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-8031000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-382000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-588000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":18815000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":8657000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":567509000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":130517000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":7.71,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":3066000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":32.4,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":22.42,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":31.11,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":40.93,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":392000.0,"StockholdersEquity_0_Q2_USD":865476000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":262000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":7316000.0,"TradingSecuritiesDebt_0_Q2_USD":338130000.0,"TradingSecuritiesDebtAmortizedCost_0_Q2_USD":338688000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":108122000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":108099000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":865476000.0,"NonoperatingIncomeExpense_2_Q2_USD":441000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":21000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_Q2_shares":25000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":258822000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":130517000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":258822000.0,"SellingAndMarketingExpense_1_Q2_USD":21188000.0,"SellingAndMarketingExpense_2_Q2_USD":41743000.0,"ShareBasedCompensation_2_Q2_USD":3438000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":34.24,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1_Q2_USD":1748000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_Q2_shares":3000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2_Q2_USD":34.49,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2_Q2_shares":120000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":40.92,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q2_shares":213000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q2_USD":37.97,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_2_Q2_USD":3438000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":107641000.0,"NonoperatingIncomeExpense_1_Q2_USD":459000.0,"NetIncomeLoss_1_Q2_USD":10828000.0,"EarningsPerShareDiluted_2_Q2_USD":0.26,"EarningsPerShareDiluted_1_Q2_USD":0.1,"EarningsPerShareBasic_2_Q2_USD":0.26,"EarningsPerShareBasic_1_Q2_USD":0.1,"DepreciationDepletionAndAmortization_2_Q2_USD":11511000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":21829000.0,"DebtSecuritiesTradingUnrealizedLoss_1_Q2_USD":578000.0,"DebtSecuritiesTradingUnrealizedGain_1_Q2_USD":20000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":138220000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":69923000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":15045000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":2797000.0,"CommonStockValue_0_Q2_USD":17243000.0,"CommonStockSharesOutstanding_0_Q2_shares":107768342.0,"CommonStockSharesIssued_0_Q2_shares":107768342.0,"CommonStockSharesAuthorized_0_Q2_shares":120000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.16,"AccountsReceivableNetCurrent_0_Q2_USD":92498000.0,"AccrualForEnvironmentalLossContingencies_0_Q2_USD":916000.0,"AccrualForEnvironmentalLossContingenciesChargesToExpenseForNewLosses_1_Q2_USD":600000.0,"AccruedEnvironmentalLossContingenciesCurrent_0_Q2_USD":300000.0,"AccruedEnvironmentalLossContingenciesNoncurrent_0_Q2_USD":616000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":0.0,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":-7415000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-24235000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":1500000.0,"Assets_0_Q2_USD":967934000.0,"AssetsCurrent_0_Q2_USD":611204000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":51119000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-24483000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AdditionalPaidInCapital_0_Q2_USD":304959000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":9636000.0,"EntityCommonStockSharesOutstanding_0_Q2_shares":107768342.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":51012000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":46843000.0,"InventoryNet_0_Q2_USD":107086000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":53940000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":6303000.0,"Liabilities_0_Q2_USD":101204000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":967934000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":427000.0,"LiabilitiesCurrent_0_Q2_USD":62673000.0,"LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_2_Q2_USD":0.0,"LineOfCreditFacilityMaximumBorrowingCapacity_0_Q2_USD":15000000.0,"MarketableSecuritiesCurrent_0_Q2_USD":338130000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":6619000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-64744000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":41057000.0,"LineOfCreditFacilityInterestRateAtPeriodEnd_0_Q2_pure":0.0109,"NetIncomeLoss_2_Q2_USD":27905000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":224000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":481000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":93706000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":22605000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":35988000.0,"Goodwill_0_Q2_USD":142613000.0,"GrossProfit_1_Q2_USD":60594000.0,"GrossProfit_2_Q2_USD":120602000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":534000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":12928000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":2100000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":6750000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":10341000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":1500000.0,"IncreaseDecreaseInInventories_2_Q2_USD":6929000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":3709000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":34655000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":107565000.0,"Ticker":"NEOG","CIK":"711377","name":"NEOGEN CORP","OfficialName":"Neogen Corporation Common Stock","form":"10-Q","period":"20211130","fy":"2022.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3158444013.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20211230"}]